GetPortalImpactFactorByIdResp(projectId=1, id=6ce21317, cover=https://img.medsci.cn/images/journal/cover/2021/TZR_202109271314376590.jpg, fullname=CANCER IMMUNOLOGY IMMUNOTHERAPY, abbr=CANCER IMMUNOL IMMUN, pyear=暂无数据, frequence=Monthly, articleNumbers=2295, citedSelf2015=3.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.77月, reviewFee=null, pageFee=2850.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0340-7004, greenSci=https://www.greensci.net/search?kw=0340-7004, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-IMMUNOL-IMMUN.shtml, medsciHotlightString=null, medsciHotlightRealtime=9.705, medsciHotlight=17.882, medsciHotlight5year=14.0166, citescore=0.0, hIndex=115, impactFactor=5.8, orgnization=Springer Science and Business Media Deutschland GmbH, orgnizationUrl=http://springerlink.com, country=Germany, countryCn=德国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.springer.com/medicine/internal/journal/262, websiteHits=15503, guideForAuthor=https://www.springer.com/medicine/internal/journal/262, guideForAuthorHits=902, submitWebsite=https://www.editorialmanager.com/ciim, submitWebsiteHits=5773, content=<p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px;">Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology. The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px;">In addition to publishing original research articles and reviews, CII also offers the following unique publication formats:</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px;">·“Focussed Research Reviews,” published together with a conference meeting report, which provide individual speakers with the opportunity to expand on the ideas and concepts they presented at the conference.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px;">·“Symposia-in-Writing,” which are virtual workshops consisting of a series of complimentary papers centered on a specific issue and addressing controversial but strategic topics in the field, usually consisting of 4-8 papers and an accompanying commentary by the convener.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px;"> CII is affiliated with the Association for Cancer Immunotherapy (CIMT), Canadian Cancer Immunotherapy Consortium (CCIC), The Japanese Association for Cancer Immunology (JACI), Network Italiano per la Bioterapia dei Tumori (NIBIT), Sociedad Española de Immunologia-Grupo Español de ImmunoTerapia (SEI-GEIT), and Cancer Immunotherapy & Immunomonitoring (CITIM).</p>, totalCites=13315, brief=CANCER IMMUNOL IMMUN杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=免疫学" >免疫学</a></strong>”子行业的中等级别杂志, articleType=论著，综述各类型文章都接收, medsciHeat=黑红, medsciComment=CANCER IMMUNOL IMMUN在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=6ce21317'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=13), ImpactFactorTagDto(id=20213, tagName=肿瘤免疫, createdHits=3), ImpactFactorTagDto(id=205, tagName=免疫, createdHits=3), ImpactFactorTagDto(id=1771, tagName=乳腺, createdHits=1), ImpactFactorTagDto(id=120, tagName=免疫学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2015, citescore=4.35), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.54), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=14.015), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=14.736), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=17.004), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=11.025), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=9.705)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=55/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Immunology and Allergy , rank=34/188), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Immunology , rank=40/198), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=51/191)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0340-7004[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CANCER IMMUNOLOGY IMMUNOTHERAPY[ta], article_number=248, article_number_cn=75, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)